This work is licensed under the Creative Commons Attribution 4.0 International License.
Willison H, Jacobs B, Doorn P. Guillain-Barré syndrome. Lancet. 2016;388:717-727.WillisonHJacobsBDoornPGuillain-Barré syndrome2016388717–72710.1016/S0140-6736(16)00339-1Search in Google Scholar
McGrogan A, Madle G, Seaman H, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology. 2009;32:150-163.McGroganAGMadleHSeamanVries CSdeThe epidemiology of Guillain-Barré syndrome worldwide200932150–16310.1159/000184748Search in Google Scholar
Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469-482.den Berg BVanCWalgaardJDrenthenCFokkeBCJacobsDoorn PAvanGuillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis201410469–48210.1038/nrneurol.2014.121Search in Google Scholar
Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012;366:2294-2304.YukiNHartungHPGuillain-Barré syndrome20123662294–230410.1056/NEJMra1114525Search in Google Scholar
Cortese A, Baldanti F, Tavazzi E, et al. Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature. J Neurol Sci. 2012;312:173-176.CorteseABaldantiFTavazziEet alGuillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature2012312173–17610.1016/j.jns.2011.08.047Search in Google Scholar
Hahn A F. Guillain-Barre syndrome. Lancet. 1998;352:635641.HahnA FGuillain-Barre syndrome199835263564110.1016/S0140-6736(97)12308-XSearch in Google Scholar
Muhammad W, Qaseem A, Amray A. Post Vaccination Guillain Barre Syndrome: A Case Report. Cureus. 2018;10: e2511.MuhammadWQaseemAAmrayAPost Vaccination Guillain Barre Syndrome: A Case Report201810e2511Search in Google Scholar
Salmon D, Proschan M, Forshee R, et al. Association between Guillain-Barré syndrome and influenza A (H1N1)2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 2013;381:1461-1468.SalmonDProschanMForsheeRet alAssociation between Guillain-Barré syndrome and influenza A (H1N1)2009 monovalent inactivated vaccines in the USA: a meta-analysis20133811461–146810.1016/S0140-6736(12)62189-8Search in Google Scholar
Sejvar J, Baughman A, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36:123-133.SejvarJBaughmanAWiseMMorganOWPopulation incidence of Guillain-Barré syndrome: a systematic review and meta-analysis201136123–13310.1159/000324710570304621422765Search in Google Scholar
Hafer-Macko C, Hsieh ST, Ho WT, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol. 1996;40:635-644.Hafer-MackoCHsiehSTHoWTet alAcute motor axonal neuropathy: an antibody-mediated attack on axolemma199640635–64410.1002/ana.4104004148871584Search in Google Scholar
Khatib H, Naous A, Ghanem S, Dbaibo G, Rajab M. Case report: Guillain-Barre syndrome with pneumococcus - A new association in pediatrics. IDCases. 2017;11:36-38.KhatibHNaousAGhanemSDbaiboGRajabMCase report: Guillain-Barre syndrome with pneumococcus - A new association in pediatrics20171136–3810.1016/j.idcr.2017.11.009577346929387550Search in Google Scholar
Li-Syue L, Chung C, Wu Y, et al. Epidemiology and prognostic factors of inpatient mortality of Guillain-Barré syndrome: A nationwide population study over 14 years in Asian country. J Neurol Sci. 2016;369:159-164.Li-SyueLChungCWuYet alEpidemiology and prognostic factors of inpatient mortality of Guillain-Barré syndrome: A nationwide population study over 14 years in Asian country2016369159–16410.1016/j.jns.2016.08.01427653883Search in Google Scholar
Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barré syndrome: incidence and mortality rates in US hospitals. Neurology. 2008;70:1608-1613.AlshekhleeAHussainZSultanBKatirjiBGuillain-Barré syndrome: incidence and mortality rates in US hospitals2008701608–161310.1212/01.wnl.0000310983.38724.d418443311Search in Google Scholar
Ruiz E, Ramalle-Gomara E, Quinones C, Martínez-Ochoa E. Trends in Guillain-Barré syndrome mortality in Spain from 1999 to 2013. Int J Neurosci. 2016;126:985-988.RuizERamalle-GomaraEQuinonesCMartínez-OchoaETrends in Guillain-Barré syndrome mortality in Spain from 1999 to 20132016126985–98810.3109/00207454.2015.109043726335975Search in Google Scholar
Stoian A, Motataianu A, Bajko Z, Balasa A. Guillain–Barré and Acute Transverse Myelitis Overlap Syndrome Following Obstetric Surgery. JCCM. 2020;6:74-79.StoianAMotataianuABajkoZBalasaAGuillain–Barré and Acute Transverse Myelitis Overlap Syndrome Following Obstetric Surgery2020674–7910.2478/jccm-2020-0008702940132104735Search in Google Scholar
Van der Berg B, Bunschoten C, A van Doorn P, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology. 2013;80:1650-1654.der Berg BVanCBunschotenvan Doorn PABCJacobsMortality in Guillain-Barre syndrome2013801650–165410.1212/WNL.0b013e3182904fcc23576619Search in Google Scholar
Yamana M, Kuwahara M, Fukumoto Y, Yoshikawa K, Takada K, Kusunoki S. Guillain-Barré syndrome and related diseases after influenza virus infection. Neurol Neuroimmunol Neuroinflamm. 2019;6:e575.YamanaMKuwaharaMFukumotoYYoshikawaKTakadaKKusunokiSGuillain-Barré syndrome and related diseases after influenza virus infection20196e57510.1212/NXI.0000000000000575662408831355311Search in Google Scholar
Tripp A. Acute transverse myelitis and Guillain-Barre overlap syndrome following influenza infection. CNS Spectr. 2008;13(9):744-746.TrippAAcute transverse myelitis and Guillain-Barre overlap syndrome following influenza infection2008139744–74610.1017/S109285290001384518849892Search in Google Scholar
Uncini A, Kuwabara S. Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry. 2015;86:1186-1195.UnciniAKuwabaraSNodopathies of the peripheral nerve: an emerging concept2015861186–119510.1136/jnnp-2014-31009725699569Search in Google Scholar
Zhang Li C, Po Lai Ho, Kintner D, Sun D, Chiu SY. Activity-Dependent Regulation of Mitochondrial Motility by Calcium and Na/K-ATPase at Nodes of Ranvier of Myelinated Nerves. J Neurosci. 2010;30:3555-3566.Li CZhangLai HoPoDKintnerDSunSYChiuActivity-Dependent Regulation of Mitochondrial Motility by Calcium and Na/K-ATPase at Nodes of Ranvier of Myelinated Nerves2010303555–356610.1523/JNEUROSCI.4551-09.2010354843220219989Search in Google Scholar
Simpson B, Rajabally Y. Sensori‐motor Guillain‐Barré syndrome with anti‐GD1b antibodies following influenza A infection. Eur J Neurol. 2009;16:e81.SimpsonBRajaballyYSensori‐motor Guillain‐Barré syndrome with anti‐GD1b antibodies following influenza A infection200916e8110.1111/j.1468-1331.2009.02569.x19222546Search in Google Scholar
Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update. Clin Neurophysiol. 2012;123:1487-1495.UnciniAKuwabaraSElectrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update20121231487–149510.1016/j.clinph.2012.01.025Search in Google Scholar
Kaida K. Guillain-Barre syndrome. Adv Exp Med Biol. 2019;1190:323-331.KaidaKGuillain-Barre syndrome20191190323–33110.1007/978-981-32-9636-7_20Search in Google Scholar
Park S, Pai K, Kim J, Shin JII. The role of interleukin 6 in the pathogenesis of hyponatremia associated with Guillain-Barré syndrome. Nefrologia. 2012;32:114.ParkSPaiKKimJShinJIIThe role of interleukin 6 in the pathogenesis of hyponatremia associated with Guillain-Barré syndrome201232114Search in Google Scholar
Press R, Ozenci V, Kouwenhoven M, Link H. Non-TH1 cytokines are augmented systematically early in Guillain-Barre syndrome. Neurology. 2002;58:476-478.PressROzenciVKouwenhovenMLinkHNon-TH1 cytokines are augmented systematically early in Guillain-Barre syndrome200258476–47810.1212/WNL.58.3.476Search in Google Scholar
Netto AB, Taly AB, Kulkarni GB, Uma Maheshwara Rao GS, Rao S. Complications in mechanically ventilated patients of Guillain–Barre syndrome and their prognostic value. J Neurosci Rural Pract. 2017;8:68–73.NettoABTalyABKulkarniGBMaheshwara Rao GSUmaSRaoComplications in mechanically ventilated patients of Guillain–Barre syndrome and their prognostic value20178687310.4103/0976-3147.193542Search in Google Scholar
Kutlesa M, Santini M, Krajinovic V, Raffanelli D, Barsić B. Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection. Neurocrit Care. 2010;13:98-100.KutlesaMSantiniMKrajinovicVRaffanelliDBBarsićAcute motor axonal neuropathy associated with pandemic H1N1 influenza A infection20101398–10010.1007/s12028-010-9365-ySearch in Google Scholar
Tam C, O’Brien S, Petersen I, Islam A, Hayward A, Rodrigues LC. Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS One. 2007;2:e344.TamCSO’BrienPetersenIIslamAHaywardARodriguesLCGuillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database20072e34410.1371/journal.pone.0000344Search in Google Scholar
Winer JB. Guillain-Barré syndrome: clinical variants and their pathogenesis. J Neuroimmunol. 2011;231:70-72.WinerJBGuillain-Barré syndrome: clinical variants and their pathogenesis201123170–7210.1016/j.jneuroim.2010.09.017Search in Google Scholar
Verity C, Stellitano L, Winstone A, Andrews N, Stowe J, Miller E. Guillain-Barré syndrome and H1N1 influenza vaccine in UK children. Lancet. 2011;378:1545-1546.VerityCStellitanoLWinstoneAAndrewsNStoweJMillerEGuillain-Barré syndrome and H1N1 influenza vaccine in UK children20113781545–154610.1016/S0140-6736(11)61665-6Search in Google Scholar
Liu S, Dong C, Ubogu E. Immunotherapy of Guillain-Barré syndrome. Hum Vaccin Immunother. 2018;14:2568-2579.LiuSDongCUboguEImmunotherapy of Guillain-Barré syndrome2018142568–257910.1080/21645515.2018.1493415631440129953326Search in Google Scholar
Stoian A, Motataianu A, Barcutean L, et al. Understanding the mechanism of action of intravenous immunoglobulins: a ten years’ experience in treating Guillain Barré syndrome. Farmacia. 2020;68:3.StoianAMotataianuABarcuteanLet alUnderstanding the mechanism of action of intravenous immunoglobulins: a ten years’ experience in treating Guillain Barré syndrome202068310.31925/farmacia.2020.3.7Search in Google Scholar
Hughes R, Swan A, Raphaël JC, Annane D, van Konigsveld R, van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain. 2007;130:2245-2257.HughesRSwanARaphaëlJCAnnaneDKonigsveld RvanDoorn PAvanImmunotherapy for Guillain-Barré syndrome: a systematic review20071302245–225710.1093/brain/awm00417337484Search in Google Scholar